In total, 938 of 2514 women (37.3%) were diagnosed with breast cancer, 630/1550 BRCA1 (40.7%) and 308/964 BRCA2 mutation carriers (32.0%, Table 1). This evidence concerns the gene BRCA2 and breast carcinoma.